Created with Sketch.
BioTalk with Rich Bendis
35 minutes | Sep 5, 2022
Brett Shealy, Executive Director, Life Sciences Banking J.P. Morgan (EP.115)
Brett Shealy, Executive Director of the Life Sciences Banking Team with J.P.Morgan, joins Rich Bendis on BioTalk to discuss his Career, BioHealth Investment, and the upcoming 2022 BioHealth Capital Region Forum/Investment Conference/Crab Trap.
16 minutes | Aug 29, 2022
7th Annual BioHealth Capital Region Crab Trap Preview
Crab Trap Judges and Sponsors, Sally Allain, MSc., MBA Head, JLABS @ Washington, DC Johnson & Johnson Innovation – JLABS, Srujana Cherukuri, Ph.D., Chief Executive Officer, Noble Life Sciences, Inc. & Lora Green, Partner, Wilson Sonsini Goodrich & Rosati, join Rich Bendis on BioTalk to preview the event taking place live on September 21st, 2022. For the first time in its history, this year’s Crab Trap winner will be eligible for a package of prizes worth more than $50,000.
36 minutes | Aug 8, 2022
Dr. Gary Disbrow, Biomedical Advanced Research and Development Authority (BARDA) (EP.113)
Dr. Gary Disbrow, Director of the Biomedical Advanced Research and Development Authority (BARDA), joins Rich Bendis on BioTalk to discuss his career, advancing research, development, and collaboration in BioHealth.
41 minutes | Jun 6, 2022
Brian Castleberry, of the Maryland Department of Commerce & Robin Wiener of Get Real Health (EP.112)
“Brian Castleberry, Maryland Department of Commerce Regional Manager - Middle East, Africa and India, Office of International Investment and Trade, and & Robin Wiener, President, Get Real Health, Join Rich Bendis on BioTalk to discuss International Collaborations, Maryland Biotech, and Collaborations.”
39 minutes | May 16, 2022
Doug Falk, Vita Therapeutics (EP.111)
Doug Falk, CEO & Co-Founder of Vita Therapeutics, joins Rich Bendis on BioTalk to discuss his career, their platforms, and moving into the University of Maryland BioPark.
30 minutes | May 4, 2022
Dave Saunders, Galen Robotics (EP.110)
Dave Saunders, CTO & Co-Founder of Galen Robotics, joins Rich Bendis on a special BioTalk before their 5/6/2022 Open House in Baltimore. RSVP to OPENHOUSE@GALENROBOTICS.COM to attend. Also, view a demo of their technology at https://bit.ly/GalenRobotics. Rich and Dave discuss Digital Surgery, Choosing Baltimore, and their Design Philosophy.
38 minutes | May 2, 2022
Mike Gill, Maryland Commerce Secretary (EP.109)
Maryland Commerce Secretary Mike Gill joins Rich Bendis on BioTalk to discuss Life Sciences in the State, growing the economy, and how we can continue building on our successes.
41 minutes | Apr 25, 2022
Ray Blanchard, Qiagen (EP.108)
Ray Blanchard, Associate Director, IP & Licensing with Qiagen joins BioTalk to discuss innovation, intellectual property, and having a large footprint in the BioHealth Capital Region.
48 minutes | Mar 21, 2022
Darryll J. Pines, University of Maryland (EP.107)
Darryll J. Pines, President, University of Maryland, Joins BioTalk to discuss all things relating the University to the BioHealth Capital Region from Quantum to Workforce Development to Diversity and Equality
42 minutes | Mar 14, 2022
Ken Malone, Early Charm Ventures (EP.106)
Ken Malone, Co-Founder and Managing Director of Early Charm Ventures, Joins BioTalk to discuss his career path, loving Baltimore, and what he sees as next for the BioHealth Capital Region
30 minutes | Feb 28, 2022
Ron Kurz, Canon Virginia, Inc. (EP.105)
Ron Kurz, Sr. Director & GM at Canon Virginia, Inc., joins BioTalk to discuss his career, growth opportunities, and Canon’s role in the BioHealth Capital Region
45 minutes | Feb 21, 2022
Marty Rosendale, Maryland Tech Council (EP.104)
Marty Rosendale, Chief Executive Officer of the Maryland Tech Council, joins BioTalk to discuss MTCs Programs, Accessing Capital, and Goals for 2022
40 minutes | Feb 14, 2022
Ron Piervincenzi, Ph.D., United States Pharmacopeia (EP.103)
Ron Piervincenzi, Ph.D., CEO of United States Pharmacopeia, returns to BioTalk to discuss USP’s growth since his last visit, the nature of their organization, and plans on hosting the 2022 BioHealth Capital Region Forum in person at their beautiful building in Rockville, Maryland.
34 minutes | Feb 7, 2022
Geoffrey Lynn, Vaccitech (EP.101)
Geoffrey Lynn, SVP, Synthetic Immunotherapies, Vaccitech, joins BioTalk to discuss his career from NIH, to CEO of Avidea, to their merger with Vaccitech.
30 minutes | Jan 24, 2022
Bill Enright, Vaccitech (EP.101)
Vaccitech CEO Bill Enright joins BioTalk with Rich Bendis to discuss his career as a serial entrepreneur, biotech executive, and BioHealth Capital Region leader.
32 minutes | Nov 8, 2021
Ellington West, Sonavi Labs (EP.100)
Ellington West, CEO & Co-founder of Sonavi Labs, joins BioTalk to discuss their building the startup, their medical device, and raising funds in the BioHealth Capital Region.
29 minutes | Nov 1, 2021
Amritha Jaishankar, PhD, Maryland Stem Cell Research Fund (MSCRF) (EP.99)
Amritha Jaishankar, PhD, Executive Director, Maryland Stem Cell Research Fund (MSCRF), joins BioTalk to discuss her career, investing in Maryland, and accelerating cures.
19 minutes | Oct 25, 2021
Mr. Hakdo Kim, President, Korea SMEs & Startups Agency KOSME)
Mr. Hakdo Kim, President, Korea SMEs & Startups Agency KOSME), joins Rich Bendis from the BHI Offices to discuss their biotech mission, their relationship with Maryland, and opportunities to expand in the United States
43 minutes | Oct 18, 2021
Seth Toback, Novavax and Divya Chadha Manek, National Institute for Health Research (NIHR) (EP.97)
A US – UK Discussion: How to Conduct Clinical Trials as Seth Toback, Vice President, Clinical Development at Novavax and Divya Chadha Manek, Director of Business Development at the National Institute for Health Research (NIHR) join Rich Bendis on BioTalk.
35 minutes | Sep 27, 2021
From the 7th Annual BioHealth Capital Region Forum - Dr. Tara Schwetz, Assistant Director for Biomedical Science Initiatives, White House Office of Science and Technology Policy (OSTP) (EP.96)
The session from the BioHealth Capital Region Forum focuses on a vision for a new science entity, the Advanced Research Projects Agency for Health (ARPA-H). This new NIH Institute would accelerate biomedical innovation and adoption of technologies and approaches to revolutionize healthcare and medicine. Tara A. Schwetz, Ph.D. is the Assistant Director for Biomedical Science Initiatives in the White House Office of Science and Technology Policy (OSTP). She is currently on detail to OSTP from her role as Associate Deputy Director (ADEPD), National Institutes of Health (NIH). During her tenure as ADEPD, Dr. Schwetz also served as the acting Director of the National Institute of Nursing Research (NINR). Prior to assuming these roles, she was the Chief of the Strategic Planning and Evaluation Branch in the Office of the Director at the National Institute of Allergy and Infectious Diseases (NIAID). Dr. Schwetz led several efforts while at NIAID, including conducting an evaluation of the Centers of Excellence for Influenza Research and Surveillance to facilitate evidence-based decision-making and developing the NIAID Strategic Plan for Tuberculosis Research. Previously, Dr. Schwetz served as the Senior Advisor to the Principal Deputy Director of NIH (DEPD), where she coordinated efforts such as Reimagine HHS, the NIH rigor and reproducibility activities, and the first NIH-Wide Strategic Plan. Dr. Schwetz also served in the dual role of the NIH Environmental influences on Child Health Outcomes (ECHO) Interim Associate Program Director and the Special Assistant to the DEPD. Prior to these roles, she was a Health Science Policy Analyst at the National Institute of Neurological Disorders and Stroke, where she helped develop the National Pain Strategy. Dr. Schwetz started her career at NIH as an AAAS Science and Technology Policy Fellow at NINR. She received a BS in biochemistry with honors from Florida State University and a PhD in biophysics from the University of South Florida, followed by a postdoctoral fellowship at Vanderbilt University.
Terms of Service
Do Not Sell My Personal Information
© Stitcher 2022